Haematology in Saudi Arabia: AI Notes for Blood Disorders and Bone Marrow Transplant

Category: Clinical Workflow & Specialty Guides | Market: Saudi Arabia | Keywords: Saudi Arabia haematology AI notes blood disorders bone marrow transplant documentation

Haematology in Saudi Arabia encompasses one of the most complex and documentation-intensive clinical subspecialties in the Kingdom. The combination of high prevalence genetic blood disorders — sickle cell disease, beta-thalassaemia, G6PD deficiency — with significant haematological malignancy burden (leukaemia, lymphoma, multiple myeloma) and a world-class bone marrow transplant programme at KFSH&RC creates a haematology documentation environment of exceptional complexity. AI medical scribing is enabling Saudi haematologists to manage this documentation breadth efficiently while maintaining the comprehensive records that haematological disease management demands.

## Saudi Haematology: A Dual Burden

Saudi haematology services carry two distinct disease burdens that coexist within the same clinical departments. Genetic haematological disorders — predominantly sickle cell disease in the Eastern Province and beta-thalassaemia — represent the chronic disease load, requiring lifelong haematology follow-up from birth. Haematological malignancies — acute myeloid and lymphoblastic leukaemia, diffuse large B-cell lymphoma, Hodgkin lymphoma, and multiple myeloma — represent the acute and intensive treatment load, driven by a growing cancer incidence in Saudi Arabia's expanding and ageing population.

## Haematology Outpatient Documentation

• Complete blood count review: systematic documentation of haemoglobin, WBC differential, platelet count, reticulocyte count, and comparison with previous values — with clinical interpretation of the trend.

• Haematological malignancy monitoring: LDH, protein electrophoresis (for myeloma), flow cytometry results, MRD (minimal residual disease) documentation for leukaemia, and imaging review.

• Chemotherapy cycle documentation: regimen, cycle number, doses, blood count adequacy for treatment, pre-treatment assessment, and previous cycle toxicity review.

• Anticoagulation management: for patients on warfarin or DOAC therapy — INR documentation, dose adjustment rationale, and bleeding or thrombotic event documentation.

## Bone Marrow Transplant Documentation

Pre-transplant workup. BMT pre-transplant documentation is extensive — donor selection, HLA typing, conditioning regimen selection, organ function baseline, infectious disease screening, and psychosocial readiness assessment. AI scribing captures the multidisciplinary pre-transplant assessment conference discussion systematically.

Transplant day records. Stem cell infusion documentation — graft details, cell dose, infusion monitoring, and any infusion reactions — generated by AI scribing from the procedural commentary creates the complete transplant day record.

Post-transplant monitoring. BMT post-transplant documentation is among the most intensive in clinical medicine — daily engraftment monitoring, GVHD assessment, infection surveillance, and immunosuppression management across the 100-day critical post-transplant period. AI scribing in the BMT unit generates structured ward round notes capturing all these parameters systematically.

GVHD documentation. Graft-versus-host disease diagnosis, grading (acute GVHD grades I–IV, chronic GVHD NIH scoring), treatment decisions, and response assessment are critical haematological documentation elements. AI scribing captures GVHD assessment and management decisions from the clinical consultation accurately.

## MDT and Tumour Board Documentation

Saudi haematology malignancy management operates through weekly tumour board meetings where complex cases are reviewed. MDT records for leukaemia, lymphoma, and myeloma — capturing the disease status, treatment response, and the team's management decision — generated by AI scribing from the tumour board discussion ensure that these critical decision points are documented without a dedicated note-taker.

## Conclusion

Saudi haematology services managing the dual burden of genetic blood disorders and haematological malignancy — alongside one of the region's most active bone marrow transplant programmes — require documentation tools that match clinical complexity with operational efficiency. AI medical scribing generates complete haematology outpatient notes, chemotherapy cycle records, BMT monitoring documentation, and MDT decisions from clinical encounters — enabling Saudi haematologists to focus on complex diagnostic and therapeutic decision-making while AI ensures the comprehensive documentation record that haematological disease care demands.

Internal links: Sickle Cell Disease GCC AI Documentation, Oncology Saudi Arabia MDT Notes Chemotherapy AI, Genetics Rare Disease Saudi Arabia AI Notes, ICU Documentation GCC Hospitals AI Critical Care